Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112937) titled 'The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study' on Aug. 1.
Study Type: Observational
Primary Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
Condition:
Rectal Cancer Patients
Recruitment Status: Recruiting
Date of First Enrollment: May 2, 2023
Target Sample Size: 150
Countries of Recruitment:
Czechia
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07112937
Published by HT Digital Content Services with permission from Health Daily Digest....